Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
21.52
-0.11 (-0.51%)
Aug 17, 2026, 2:45 PM EDT - Market open
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $2.4 billion as of August 17, 2026. Its market cap has increased by 236.14% in one year.
Market Cap
2.40B
Enterprise Value
2.15B
1-Year Change
236.14%
Ranking
Category
Stock Price
$21.52
ChartMarket Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $2.40B, an increase of 124.26%. That is a compound annual growth rate of 19.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 2.40B | 80.75% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.81B |
| Regencell Bioscience Holdings | 2.70B |
| BioCryst Pharmaceuticals | 2.49B |
| Bausch Health Companies | 2.43B |
| Prestige Consumer Healthcare | 2.43B |
| HUTCHMED (China) | 2.18B |
| Trulieve Cannabis | 1.86B |
| Perrigo Company | 1.81B |